[go: up one dir, main page]

SI3193826T1 - Orodisperzibilen filmski sestavek, ki obsega enalapril, za zdravljenje hipertenzije pri pediatrični populaciji - Google Patents

Orodisperzibilen filmski sestavek, ki obsega enalapril, za zdravljenje hipertenzije pri pediatrični populaciji

Info

Publication number
SI3193826T1
SI3193826T1 SI201530574T SI201530574T SI3193826T1 SI 3193826 T1 SI3193826 T1 SI 3193826T1 SI 201530574 T SI201530574 T SI 201530574T SI 201530574 T SI201530574 T SI 201530574T SI 3193826 T1 SI3193826 T1 SI 3193826T1
Authority
SI
Slovenia
Prior art keywords
enalapril
hypertension
treatment
film composition
pediatric population
Prior art date
Application number
SI201530574T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthymios Koutris
Vasiliki Samara
Ionna Koutri
Anastasia Kalaskani
Lida Kalantzi
Andreas Kakouris
Amalia Diakidou
George Gotzamanis
Zaharias Georgousis
Louiza Konstanti
Original Assignee
Pharmathen S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen S.A. filed Critical Pharmathen S.A.
Publication of SI3193826T1 publication Critical patent/SI3193826T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201530574T 2014-07-31 2015-06-19 Orodisperzibilen filmski sestavek, ki obsega enalapril, za zdravljenje hipertenzije pri pediatrični populaciji SI3193826T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2014002095 2014-07-31
EP15732161.3A EP3193826B1 (en) 2014-07-31 2015-06-19 Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
PCT/EP2015/001243 WO2016015798A1 (en) 2014-07-31 2015-06-19 Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population

Publications (1)

Publication Number Publication Date
SI3193826T1 true SI3193826T1 (sl) 2019-02-28

Family

ID=53491483

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201530574T SI3193826T1 (sl) 2014-07-31 2015-06-19 Orodisperzibilen filmski sestavek, ki obsega enalapril, za zdravljenje hipertenzije pri pediatrični populaciji

Country Status (15)

Country Link
US (1) US20170165315A1 (sl)
EP (1) EP3193826B1 (sl)
CY (1) CY1121141T1 (sl)
DK (1) DK3193826T3 (sl)
ES (1) ES2705610T3 (sl)
HR (1) HRP20190083T1 (sl)
HU (1) HUE041705T2 (sl)
LT (1) LT3193826T (sl)
PL (1) PL3193826T3 (sl)
PT (1) PT3193826T (sl)
RS (1) RS58120B1 (sl)
SI (1) SI3193826T1 (sl)
SM (1) SMT201900031T1 (sl)
TR (1) TR201819662T4 (sl)
WO (1) WO2016015798A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020500220A (ja) 2016-11-15 2020-01-09 クラリア ファーマ ホールディング エービー 医薬製剤
GB201709141D0 (en) * 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
CA3096919A1 (en) * 2018-04-13 2019-10-17 Zim Laboratories Limited Composition of active ingredient loaded edible ink and methods of making suitable substrates for active ingredient printing on orodispersible films
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
GR20200100430A (el) * 2020-06-01 2022-01-13 Κυριακος Ηλια Κυπραιος Ταχεως διαλυομενες στοματικες ταινιες για τη χορηγηση δια της στοματικης οδου φαρμακων και λοιπων βιοδραστικων ουσιων σε ανθρωπους
CN120435284A (zh) * 2022-11-14 2025-08-05 新加坡国立大学 将可注射药物配制成薄膜或薄片的方法及其系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4510083A (en) 1982-05-07 1985-04-09 Merck & Co., Inc. Process for preparing polypeptides
US4830853A (en) 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
YU48602B (sh) 1991-11-25 1998-12-23 Krka Tovarna Zdravil P.O. Postupak za dobijanje stabilne formulacije soli enalaprila
CA2128199C (en) 1994-07-15 1997-02-04 Bernard Charles Sherman Stable solid pharmaceutical compositions containing enalapril maleate
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20080220029A1 (en) * 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
EP2732813A1 (en) * 2012-11-14 2014-05-21 Hexal AG Orodispersible film compositions

Also Published As

Publication number Publication date
LT3193826T (lt) 2019-01-25
EP3193826A1 (en) 2017-07-26
US20170165315A1 (en) 2017-06-15
HRP20190083T1 (hr) 2019-03-08
EP3193826B1 (en) 2018-10-17
WO2016015798A9 (en) 2016-03-31
HUE041705T2 (hu) 2019-05-28
WO2016015798A1 (en) 2016-02-04
TR201819662T4 (tr) 2019-01-21
PL3193826T3 (pl) 2019-07-31
DK3193826T3 (en) 2019-02-11
PT3193826T (pt) 2019-01-23
ES2705610T3 (es) 2019-03-26
CY1121141T1 (el) 2020-05-29
SMT201900031T1 (it) 2019-02-28
RS58120B1 (sr) 2019-02-28

Similar Documents

Publication Publication Date Title
LT3197472T (lt) Rekombinantinių baltymų be fenilalanino naudojimas gydant fenilketonuriją
ZA201605822B (en) Dental implant
ZA201605724B (en) Dental implant
GB201404049D0 (en) Dental implant
FI20146023A7 (fi) Hammas- ja kielituki
PL3215117T3 (pl) Listek deksametazonu do podawania doustnego
PL3134026T3 (pl) System implantologiczny
SI3193826T1 (sl) Orodisperzibilen filmski sestavek, ki obsega enalapril, za zdravljenje hipertenzije pri pediatrični populaciji
EP3173024A4 (en) Dental radiography device
IL252116A0 (en) Pharmaceutical granule formulations containing dimethyl fumarate
ZA201703398B (en) Pharmaceutical composition and methods
PL3232998T3 (pl) Urządzenie medyczne do wykonywania ileostomii i/albo jejunostomii
IL242860A0 (en) A self-propelled dental device
GB201502268D0 (en) Dental composition and use
GB201406172D0 (en) Therapy and pharmaceutical composition
LT3209294T (lt) Farmacinė kompozicija, skirta panaudoti nosies gleivinės trofizmo padidinimui
EP3189810A4 (en) Dental implant and set thereof
PL3131572T3 (pl) Analog apc do zastosowania w zaleczaniu rany
IL250235A0 (en) A peptide derived from urlc10 and a component containing it
IL250215B (en) A peptide derived from cdca1 and a component containing it
GB201513543D0 (en) Compositions for use in the treatment of diabetes
EP3110453A4 (en) Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions
GB201420805D0 (en) Ligatures and use thereof
GB201417597D0 (en) Film dispenser and method for manufacture thereof
ZA201801788B (en) Lysobactin for use in the treatment of bovine mastitis